- 360 WallStreet
- Posts
- Massive gains sparked by mergers & breakthrough data
Massive gains sparked by mergers & breakthrough data
Plus Jeff B. Live at 11AM EST
In partnership with
& VantagePoint
Good day, 360!
Here are some of our top movers today. And don’t forget to join us in Market Masters - at 11AM EST today - the hottest trading room around 🔥. Be the best prepared trader on the Street!
FOCUS LIST🔎
GRYP - Up over 280% in the pre-market after announcing merger with American Bitcoin
KDLY - Up over 400% in pre on no apparent news
CTMX - Up over 50% in pre after announcing positive interim data from Phase 1 dose escalation study of EpCAM antibody drug conjugate (CX-2051) candidate in patients with advanced Colorectal Cancer (CRC)
In partnership with
Your job called—it wants better business news
Welcome to Morning Brew—the world’s most engaging business newsletter. Seriously, we mean it.
Morning Brew’s daily email keeps professionals informed on the business news that matters, but with a twist—think jokes, pop culture, quick writeups, and anything that makes traditionally dull news actually enjoyable.
It’s 100% free—so why not give it a shot? And if you decide you’d rather stick with dry, long-winded business news, you can always unsubscribe.
HOTLIST🔥
GRYP - Up over 280% in the pre-market after announcing merger with American Bitcoin
Gryphon Digital Mining Inc. (GRYP) operates as a bitcoin mining company in the United States. The company operates mining computers and hosts mining data centers.
In the pre-market this morning, the company announced that it has entered into a definitive merger agreement with American Bitcoin Corp., a Bitcoin accumulation platform focused on building America's Bitcoin infrastructure backbone, pursuant to which Gryphon will acquire American Bitcoin in a stock-for-stock merger transaction.
Upon closing, the combined company will operate under the American Bitcoin brand, led by the management and board of directors of American Bitcoin. The combined company is expected to trade on Nasdaq under the ticker symbol "ABTC."
Shares of GRYP traded up over 280% in the pre-market in reaction to the news.
The $1.50 area acted as support in the pre-market and will be an important level to watch.
Above it, targets to the upside are $2, $2.50, $2.88 and then the pre-market high at $4.91.
Below $1.50, targets to the downside are $1.33, $1 and then a gap fill at $0.52.
KDLY - Up over 400% in pre on no apparent news
Kindly MD Inc. (KDLY) is a healthcare and healthcare data company that provides direct health care services to patients integrating prescription medicine and behavioral health services.
Despite no apparent news KDLY found buyers this morning and traded up over 400% in the pre-market in rapid fashion. This is one for day traders to have their eye on today.
The $18 area acted as support in the pre-market and will be an important level to watch.
Above it, targets to the upside are $21, $24, $26 and then the pre-market high at $26.86. Beyond that there is blue sky all-time highs.
Below $18, targets to the downside are $16.97, $14, $12, $10, $8, $6 and then a gap fill at $3.90.
*together with VantagePoint
🔥ATTN: This Trade Is Too Big to Ignore🔥
A.I. Trader Daniel Santiago’s Got A Heavy Hitter Lined Up!
Jeff Bishop’s Getting Details. So Are You!
Get In On This Trade. It’s Free!
CTMX - Up over 50% in pre after announcing positive interim data from Phase 1 dose escalation study of EpCAM antibody drug conjugate (CX-2051) candidate in patients with advanced Colorectal Cancer (CRC)
CytomX Therapeutics Inc. (CTMX) operates as an oncology-focused biopharmaceutical company that focuses on developing novel conditionally activated biologics localized to the tumor microenvironment.
In the pre-market this morning, the company announced positive interim Phase 1 data for its EpCAM PROBODY® ADC candidate, CX-2051, in advanced, late-line CRC. The data are as of an April 7th 2025 data cutoff from the ongoing CTMX-2051-101 Phase 1 study.
Highlights include:
28% confirmed response rate (5/18) per RECIST v1.1 in unselected patients across doses prioritized for expansion (7.2, 8.6 and 10 mg/kg Q3W) -
3 of 7 evaluable patients (43%) with confirmed responses at upper expansion dose (10 mg/kg Q3W)
Median progression free survival of 5.8 months as of April 7th 2025 data cutoff -
Encouraging initial safety profile with no dose limiting toxicities at data cutoff -
Planning Phase 2 study initiation in 1H 2026 -
Conference call on Monday, May 12 at 8:00 a.m. ET
Shares of CTMX traded up over 50% in the pre-market in reaction to the news.
The $1.35 area acted as support in the pre-market and will be an important level to watch.
Above it, targets to the upside are $1.50 and then the pre-market high at $1.60. Beyond that, $1.70, $1.90 and $2.30 come into play.
Below $1.35, targets to the downside are $1.30, $1.17, $1 and a gap fill at $0.9284.
MARKET NEWS 📰
Don't miss out on our MOBILE ALERTS! Some of these alerts have rocketed 🚀past the MOON 🌝. Text “RAGE” to 1-(888) 487-1534 📲.
*Disclosure: By texting “RAGE” to 1-(888) 487-1534, you agree to receive promotional messages sent via an autodialer. You also agree to the terms of service and privacy policy. This agreement isn’t a condition of any purchase. Message frequency varies. Message and data rates may apply. Reply STOP to opt out; HELP for more information.
DISCLAIMER: To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website, application or other service ("Services"), please review our full disclaimer located at https://ragingbull.com/disclaimer
FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision.
RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment.
RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. Employees, owners, and other service providers of https:// ragingbull. com or RagingBull.com LLC are paid in whole or in part by commission based on their sales of Services to subscribers.
RagingBull.com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements. In the event that any suit or action is instituted as a result of doing business with RagingBull. com, LLC and/or its affiliates or if any suit or action is necessary to enforce or interpret these Terms of Service, RagingBull. com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements in addition to any other relief to which it may be entitled.
*Sponsored Content: If you purchase anything through a link in this email other than RagingBull (RB) services, you should assume that we have an affiliate relationship with the company providing the product that you purchase, and that we will be paid in some way. RB is not responsible for any content hosted on affiliate’s sites and it is the affiliate’s responsibility to ensure compliance with applicable laws. We recommend that you do your own independent research before purchasing anything. While we believe in the companies we form affiliate relationships with, please don’t spend any money on these products unless you believe they will help you achieve your goals.
WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services except possibly by advertisers in this email. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication.
Reply